At the event, Szijjártó noted that the Hungarian pharma industry’s production value was 910 billion forints (EUR 2.5bn) last year, up by five percent from 2018.

Fully 86% of that volume was exported, he added.

The Hungarian pharmaceutical industry has long traditions, and is seen as a “breakout sector” where all funding turns a profit, Szijjártó said.

The government will do everything in its power to keep Hungarian pharma among the best in the world, Szijjártó said.

The freshly inaugurated office has 68 workstations, a cafeteria and a conference room.

CEO Gábor Orbán noted that Richter’s investments in Debrecen have created a biotech base without peer in Hungary or the region.

MTI Photo: Zsolt Czeglédi